Belite Bio, Inc, ADR (BLTE) PT Raised to $266 at Cantor Fitzgerald After Higher WAC Announced Mar 3, 2026 07:44AM
Belite Bio (BLTE) Reiterated at Overweight by Cantor Fitzgerald Jan 16, 2026 07:08AM
Belite Bio prices $350 million public offering at $154 per share Dec 1, 2025 10:37PM
Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares Dec 1, 2025 10:37PM
Belite Bio launches public offering of American depositary shares Dec 1, 2025 04:20PM


Dec 1, 2025 04:20PM Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares
Nov 24, 2025 06:12AM Cantor Fitzgerald Assumes Belite Bio, Inc, ADR (BLTE) at Overweight
May 15, 2025 07:23AM Cantor Fitzgerald Reiterates Overweight Rating on Belite Bio, Inc, ADR (BLTE)
Mar 17, 2025 07:06AM Cantor Fitzgerald says 15% of biotech companies down 40% or more
May 6, 2024 08:15AM Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant
Jul 28, 2023 06:33AM Cantor Fitzgerald Starts Belite Bio, Inc, ADR (BLTE) at Overweight
May 31, 2023 06:02AM Belite Bio (BLTE) prices 2 million share offering at $15/ADS
May 30, 2023 08:49PM Belite Bio Announces Pricing of $30 Million Underwritten Public Offering of American Depositary Shares and Warrants
May 30, 2023 04:01PM Belite Bio (BLTE) to offer ADS and warrants
May 30, 2023 04:01PM Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares and Warrants